Internal: Archive

Swiss doctor among new European astronaut crew

This content was published on Nov 23, 2022 Marco Sieber from Bern has been chosen as one of five new “career astronauts” by the European Space Agency.

When does corporate sponsorship become a rubber stamp?

This content was published on Nov 23, 2022 Even companies that sponsor good causes find themselves in trouble these days. Is it time to rethink corporate sponsorship?

Credit Suisse approves CHF4bn fundraise to underwrite restructuring

This content was published on Nov 23, 2022 Credit Suisse shareholders have approved a CHF4 billion capital raise amid a large-scale exodus of client assets and an expected CHF1.5bn quarterly loss.

Eine Statue, die das Ohr so hält, als würde sie der Bevölkerung zuhören.

How democracy features in local Chinese politics

This content was published on Nov 23, 2022 Participatory budgeting is not restricted to democracies. It also exists in China – although not through democratic conviction.

OECD lowers growth forecast for Swiss economy

This content was published on Nov 22, 2022 The Organisation for Economic Development and Cooperation expects Swiss GDP to grow by 2.1% in 2022, not 2.5% as forecasted.

Beer sales bounce back in Switzerland post-pandemic

This content was published on Nov 22, 2022 The sunny weather, along with the end of Covid restrictions, boosted the amount of beer drunk over the past year, brewers have said.

Swiss gender pay gap among the widest in Europe

This content was published on Nov 22, 2022 In 2020, women in Switzerland earned on average 18.4% less than men for equivalent work, according to new figures.

Axpo to invest CHF1.5 billion in Swiss solar projects

This content was published on Nov 22, 2022 The plans involve building solar plants in the Alps and in lower-lying regions by 2030, Switzerland's top energy firm said on Tuesday.

Rolex plans new factory and 2,000 jobs in Switzerland

This content was published on Nov 22, 2022 The luxury Swiss watch brand Rolex hopes to invest in a new production site at Bulle in western Switzerland that should result in 2,000 new jobs.

Paying to survive – the deadly toll of breast cancer in Kenya

This content was published on Nov 22, 2022 In Kenya, the high price of drugs like trastuzumab, which Roche sells as Herceptin, is one reason why breast cancer is still seen as a death sentence.

Page 335 of 2840

First … 333 334 335 336 337 … Last

Internal: Archive

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Internal: Archive

More

Swiss doctor among new European astronaut crew

More

When does corporate sponsorship become a rubber stamp?

More

Credit Suisse approves CHF4bn fundraise to underwrite restructuring

More

How democracy features in local Chinese politics

More

OECD lowers growth forecast for Swiss economy

More

Beer sales bounce back in Switzerland post-pandemic

More

Swiss gender pay gap among the widest in Europe

More

Axpo to invest CHF1.5 billion in Swiss solar projects

More

Rolex plans new factory and 2,000 jobs in Switzerland

More

Paying to survive – the deadly toll of breast cancer in Kenya

Popular Stories

Most Discussed